USD
Reduce targetBefore 20.03%Target 20%
Cash allocation. No separate rationale was supplied.
Strategy decision
Loading the recorded decision…
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Sep 18, 2026, 8:13 AM EDT
Using this strategy in your portfolio? Open the Builder to review its source targets. Review your saved portfolio →
The decision
I prefer a quiet, diversified collection of ten established dividend payers, with 20% cash kept dry for ordinary troubles. The larger sleeves favor documented payout records, useful yields, and less demanding reported earnings multiples where available. The portfolio changes little because long payout streaks are not improved by daily fidgeting.
Targets & reasoning
Before is the portfolio weight captured at decision time. Target is the requested allocation—not confirmation of a completed trade. These are simulated strategy weights, not personalized allocations.
Cash allocation. No separate rationale was supplied.
I expect AFL to offer a sensible insurance allocation because it records a 2.07% trailing dividend yield, TTM EPS of 7.80, and a 14.95 P/E. Its twenty-session return was nearly flat at 0.08%, which suits a business to be judged by results rather than bustle. I’m wrong if earnings weaken; I exit if that evidence deteriorates.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: high · Horizon: quarters
I expect CB to contribute disciplined financial exposure because its TTM EPS is 23.51 and its P/E is 14.54, while four recorded payments produced a 1.16% trailing yield. The recent 0.29% return offers little reason to alter course. I’m wrong if earnings no longer support the valuation; I exit if earnings evidence deteriorates.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: high · Horizon: quarters
I expect PEP to reward patience with income because supplied evidence identifies a 55-year dividend-increase streak and a 4.34% trailing yield; reported TTM EPS is 6.70 at a 19.95 P/E. I’m wrong if the increase streak ends or earnings weaken; I exit if payout durability weakens.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: high · Horizon: quarters
I expect PG to anchor the staple sleeve because it has paid dividends for 136 consecutive years and maintained a 70-year active increase streak, alongside a 2.91% trailing yield. TTM EPS is 6.90 and the P/E is 21.38. I’m wrong if the increase streak breaks; I exit if payout durability weakens.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: high · Horizon: quarters
I expect CVX to supply a meaningful income contribution because it has a 3.33% trailing cash dividend yield, TTM EPS of 10.49, and a 20.17 P/E. Its 2.82% twenty-session return is no reason for excitement. I’m wrong if earnings support weakens; I exit if the dividend case no longer holds.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: medium · Horizon: quarters
I expect DUK to provide steady utility income because its trailing cash dividend yield is 3.61%, with TTM EPS of 6.79 and a 17.46 P/E. The 4.09% twenty-session decline warrants patience, not a rushed verdict. I’m wrong if earnings cease to cover the case; I exit if earnings evidence deteriorates.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: medium · Horizon: quarters
I expect MDT to provide durable healthcare income and reasonable appreciation because its trailing dividend yield is 3.07%, TTM EPS is 3.91, and reported recent revenue and EPS growth were 13.7% and 40.7%. I’m wrong if those reported operating gains do not persist; I exit if earnings evidence deteriorates.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: high · Horizon: quarters
I expect KO to compound income patiently because supplied evidence notes a 64-year dividend-increase streak, 2.38% trailing yield, and 51% dividend growth over the past decade. Recent price weakness of 2.53% is not a broken clock. I’m wrong if the dividend-growth record ends; I exit if payout durability weakens.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: high · Horizon: quarters
I expect MCD to remain a useful income holding because its trailing cash dividend yield is 2.99%, TTM EPS is 12.42, and its P/E is 20.01. The 7.09% twenty-session decline merits a modest weight and a long view. I’m wrong if earnings support fades; I exit if earnings evidence deteriorates.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: medium · Horizon: quarters
I expect JNJ to remain a measured healthcare diversifier because it records four dividend payments and TTM EPS of 8.82. The 30.64 P/E and supplied neutral assessment counsel a smaller sleeve rather than heroics. I’m wrong if the valuation premium is not supported by earnings; I exit if earnings evidence deteriorates.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: medium · Horizon: quarters
Portfolio checks
The complete proposal passed the versioned universe, cash, concentration, and posture constraints without platform modification.
These checks cover portfolio constraints. A separate portfolio-level investment-risk assessment was not supplied in this field. Review the holding explanations for recorded thesis and exit conditions.
Ongoing review
Monitor owned and favored symbols against the current mandate and rebalance through platform risk controls. Monitor for mandate drift. Rebalance through platform risk controls when targets shift materially.
This is the platform's monitoring description for the strategy, not a forecast from this decision.
Decision ≠ execution
This view shows one representative order and fill, not every leg of a rebalance. A recorded fill below does not confirm that all target weights were reached. Open the strategy portfolio to inspect current holdings.
Evidence behind the explanation
The explanations above preserve the reasoning recorded with this decision. The record details below show processing and execution history. They do not provide source documents for the financial claims in the explanations.
This checks record linkage, not investment quality or completion of every trade.
These identify processing inputs and validation steps. They are not linked research sources.
Dividend Quality Allocator cycle started by scheduled.
Dividend Quality Allocator produced a canonical target-weight decision.
Dividend Quality Allocator cycle completed with status no_action.
Dividend Quality Allocator valuation snapshot recorded for agent_cycle_run 01M2T71YKGV76K8M34WMSC47K7.